...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR 2018

Late Breaking and Clinical Trial abstract titles for AACR were posted last week. I didn't see any titles for Zenith. I inquired with Clayton and he stated that Zenith will not be presenting an abstract at AACR. Also, the full Asangani abstract is now posted, but no meniton of Zenith despite him listing Zenith in his disclosures.

Share
New Message
Please login to post a reply